NEW YORK, May 5, 2022 /PRNewswire/ — Insilico Medicine (“Insilico”), a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, announced today that the company has nominated a preclinical candidate (PCC) targeting methionine adenosyltransferase 2A (MAT2A) from AI-designed molecules for the treatment of methylthioadenosine phosphorylase (MTAP)-deleted cancers. The PCC is part of Insilico’s growing portfolio of synthetic lethality assets in development. …
NEW YORK, May 6, 2022 /PRNewswire/ — Insilico Medicine (“Insilico”), a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, announced today that the company has nominated a preclinical candidate (PCC) targeting methionine adenosyltransferase 2A (MAT2A) from AI-designed molecules for the treatment of methylthioadenosine phosphorylase (MTAP)-deleted cancers. The MAT2A program is part of Insilico’s growing portfolio of synthetic lethality assets in …
Dr. Jane
February 16, 2021
There’s no shortage of podcasts devoted to veterinary medicine by Dr. Andy Roark’s “Cone of Shame” and “Uncharted” to Dr. Ernie Ward and Beckie Mossor’s Veterinary Viewfinder and VETgirl’s Veterinary Continuing Education. Not to mention the AVMA podcast “My Veterinary Life”, which was first broadcast in February 2019 and in which guests talk about their career experiences. Regardless of the …
